Anticipating dissemination of cancer genomics in public health: A theoretical approach to psychosocial and behavioral challenges

Annals of Behavioral Medicine

Volumn 34, Issue 3, 2007, Pages 275-286

  Hay, Jennifer L ^a   Meischke, Hendrika W ^b   Bowen, Deborah J ^b   Mayer, Joni ^c   Shoveller, Jeanne ^d   Press, Nancy ^e   Asgari, Maryam ^f   Berwick, Marianne ^g   Burke, Wylie ^h  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF OREGON   (United States)

^f KAISER PERMANENTE   (United States)

^g UNIVERSITY OF NEW MEXICO   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR CHANGE; CANCER CONTROL; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; GENETIC SUSCEPTIBILITY; GENOMICS; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; MELANOMA; PATIENT EDUCATION; PATIENT PARTICIPATION; PSYCHOSOCIAL ENVIRONMENT; PUBLIC HEALTH SERVICE; RISK REDUCTION; THEORETICAL STUDY;

DISCLOSURE; GENOMICS; HEALTH BEHAVIOR; HUMANS; NEOPLASMS; PSYCHOLOGICAL THEORY; PSYCHOLOGY; PUBLIC HEALTH;

EID: 37249078152     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02874552     Document Type: Article

References (134)

1. Collins FS, Green ED, Guttmacher AE, Guyer MS: A vision for the future of genomics research. Nature. 2003, 422:835-847.
2. Lerman C, Croyle RT, Tercyak KP, Hamann H: Genetic testing: Psychological aspects and implications. Journal of Consulting and Clinical Psychology. 2002, 70:784-797.
3. Patenaude AF, Guttmacher AE, Collins FS: Genetic testing and psychology. New roles, new responsibilities. The American Psychologist. 2002, 57:271-282.
4. de Snoo FA, Bergman W, Gruis NA: Familial melanoma: A complex disorder leading to controversy on DNA testing. Familial Cancer. 2003, 2:109-116.
5. Perera FP: Environment and cancer: Who are susceptible? Science. 1997, 278:1068-1073.
6. Khoury MJ, Group CGW: From genes to public health: Applications of genetics in disease prevention. American Journal of Public Health. 1996, 86:1717-1722.
7. Khoury MJ, Thrasher JF, Burke W, et al.: Challenges in communicating genetics: a public health approach. Genetics in Medicine. 2000, 2:198-202.
8. Efferth T, Volm M: Pharmacogenetics for individualized cancer chemotherapy. Pharmacology & Therapeutics. 2005, 107:155-176.
9. Gritz ER, Peterson S: Intersection of genomic information and behavioral sciences. In Hernanadez LM (ed), Implications of Genomics for Public Health: Workshop Summary. Washington, DC: Institute of Medicine, The National Academies Press, 2005, 24.
10. Jemal A, Devesa SS, Hartge P, Tucker MA: Recent trends in cutaneous melanoma incidence among whites in the United States. Journal of the National Cancer Institute. 2001, 93:678-683.
11. Goldstein AM, Tucker MA: A piece of the melanoma puzzle. Journal of the National Cancer Institute. 2005, 97:1486-7.
12. Skinner MA, Moley JA, Dilley WG, et al.: Prophylactic thyroidectomy in multiple endocrine neoplasia type 2 A. New England Journal of Medicine. 2005, 353:1105-1113.
13. Begg CB, Orlow I, Hummer AJ, et al.: Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. Journal of the National Cancer Institute. 2005, 97:1507-1515.
14. Bishop DT, Demenais F, Goldstein AM, et al.: Geographical variation in the penetrance of CDKN2A mutations for melanoma. Journal of the National Cancer Institute. 2002, 94:894-903.
15. Valverde P, Healy E, Sikkink S, et al.: The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Human Molecular Genetics. 1996, 5:1663-1666.
16. Chaudru V, Laud K, Avril MF, et al.: Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiology, Biomarkers & Prevention. 2005, 14:2384-2390.
17. Duffy DL, Box NF, Chen W, et al.: Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Human Molecular Genetics. 2004, 13:447-4461.
18. Flanagan N, Healy E, Ray A, et al.: Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Human Molecular Genetics. 2000, 9:2531-2537.
19. Goldstein AM, Landi MT, Tsang S, et al.: Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiology, Biomarkers & Prevention. 2005, 14:2208-2212.
20. Kanetsky PA, Ge F, Najarian D, et al.: Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiology, Biomarkers & Prevention. 2004, 13:808-819.
21. Kennedy C, ter Huurne J, Berkhout M, et al.: Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. The Journal of Investigative Dermatology. 2001, 117:294-300.
22. Landi MT, Kanetsky PA, Tsang S, et al.: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. Journal of the National Cancer Institute. 2005, 97:998-1007.
23. Matichard E, Verpillat P, Meziani R, et al.: Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. Journal of Medical Genetics. 2004, 41:e13.
24. Sturm RA: Skin colour and skin cancer - MC1R, the genetic link. Melanoma Research. 2002, 12:405-416.
25. Berg AO: Clinical use of genomic information. In Hernanadez LM (ed), Implications of Genomics for Public Health: Workshop Summary. Washington, DC: Institutes of Medicine, The National Academies Press, 2005, 22.
26. American Medical Association: Multiple genetic testing. Hastings Center Report. 1998, 28:15-21.
27. Marteau TM, Weinman J: Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Social Science & Medicine. 2006, 62:1360-1368.
28. Cameron LD, Leventhal H (eds): The Self-Regulation of Health and Illness Behavior. New York: Routledge, 2003.
29. Walter FM, Emery J, Braithwaite D, Marteau TM: Lay understanding of familial risk of common chronic diseases: A systematic review and synthesis of qualitative research. Annals of Family Medicine. 2004, 2:583-594.
30. McAllister M: Predictive genetic testing and beyond: A theory of engagement. Journal of Health Psychology. 2002, 7:491-508.
31. McAllister M: Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clinical Genetics. 2003, 64:179-189.
32. Walter FM, Emery J: "Coming down the line": Patients' understanding of their family history of common chronic disease. Annals of Family Medicine. 2005, 3:405-414.
33. Harvard Center for Cancer Prevention: Your Disease Risk. The Source on Prevention, 2005. Retrieved April 2007 from http://www.yourdiseaserisk. harvard.edu
34. Blalock SJ, DeVellis BM, Afifi RA, Sandler RS: Risk perceptions and participation in colorectal cancer screening. Health Psychology. 1990, 9:792-806.
35. Lipkus IM, Skinner CS, Dement J, et al.: Increasing colorectal cancer screening among individuals in the carpentry trade: Test of risk communication interventions. Preventive Medicine. 2005, 40:489-501.
36. Weinstein ND, Atwood K, Puleo E, et al.: Colon cancer: Risk perceptions and risk communication. Journal of Health Communication. 2004, 9:53-65.
37. Lipkus IM, Skinner CS, Green LS, et al.: Modifying attributions of colorectal cancer risk. Cancer Epidemiology, Biomarkers & Prevention. 2004, 13:560-566.
38. Ponder M, Lee J, Green J, Richards M: Family history and perceived vulnerability to some common diseases: A study of young people and their parents. Journal of Medical Genetics. 1996, 33:485-492.
39. Weinstein ND: Why it won't happen to me: perceptions of risk factors and susceptibility. Health Psychology. 1984, 3:431-457.
40. Weinstein ND: Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. Journal of Behavioral Medicine. 1987, 10:481-500.
41. Senior V, Marteau TM, Peters TJ: Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents' responses to neonatal screening for familial hypercholesterolaemia. Social Science Medicine. 1999, 48:1857-1860.
42. Acheson LS, Crabtree BF: How do people interpret their family histories of diabetes, coronary disease, or cancer? Annals of Family Medicine. 2004, 2:532-533.
43. Finnegan Jr. JR, Viswanath K: Communication theory and health behavior change: The media studies framework. In Glanz K, Rimer BK, Lewis FM (eds), Health Behavior and Health Education. Theory, Research and Practice. San Francisco: Jossey-Bass, 2002.
44. Street Jr. RL: Communication in medical encounters: An ecological perspective. In Thompson TL, Dorsey AM, Miller KI, Parrott R (eds), Handbook of Health Communication. Mahwah, NJ: Lawrence Erlbaum Associates, 2003, 63-89.
45. Freimuth V: Educating the public. In Hernanadez LM (ed), Implications of Genomics for Public Health: Workshop Summary. Washington, DC: Institute of Medicine, The National Academies Press, 2005, 37.
46. Petersen A: Biofantasies: genetics and medicine in the print news media. Social Science Medicine. 2001, 52:1255-1268.
47. Kerr A, Cunningham-Burley S, Amos A: Drawing the line: An analysis of lay people's discussions about the new genetics. Public Understanding of Science. 1998, 7:113-133.
48. Kerr A, Cunningham-Burley S, Amos A: The new genetics and health: Mobilizing lay expertise. Public Understanding of Science. 1998, 7:41-60.
49. Harris T: Gene find brings hope for glaucoma sufferers. The Weekend Australian. March 1997, 44:28-29.
50. Ariail K, Watts C, Bowen D: Retention in a breast cancer risk information trial: Motivations of a population-based sample of women. Health Education & Behavior. 2006, 33:591-603.
51. Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W: Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiology. Biomarkers & Prevention. 1999, 8:369-375.
52. Burke W, Culver JO, Bowen D, et al.: Genetic counseling for women with an intermediate family history of breast cancer. American Journal of Medical Genetics. 2000, 90:361-368.
53. Bowen DJ, Burke W, Yasui Y, McTiernan A, McLeran D: Effects of risk counseling on interest in breast cancer genetic testing for lower risk women. Genetics in Medicine. 2002, 4:359-365.
54. Mesters I, Ausems M, Eichhorn S, Vasen H: Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): A retrospective exploratory study. Familial Cancer. 2005, 4:163-167.
55. Bowen DJ, Battuello KM, Raats M: Marketing genetic tests: Empowerment or snake oil? Health Education & Behavior. 2005, 32:676-685.
56. Myriad: Myriad genetics to launch melaris - A predictive medicine test for melanoma (press release). Salt Lake City, UT: September 27, 2001. Retrieved April 28, 2006 from http://www.myriad.com/news/release/273644
57. Kefford R, Bishop JN, Tucker M, et al.: Genetic testing for melanoma. The Lancet Oncology. 2002, 3:653-654.
58. Vadaparampil ST, Wideroff L, Olson L, Viswanath K, Freedman AN: Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility. American Journal of Medical Genetics A. 2005, 135:41-46.
59. Bubela TM, Caulfield TA: Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers. Canadian Medical Association Journal. 2004, 170:1399-1407.
60. Condit C: What is "public opinion" about genetics? Nature Reviews Genetics. 2001, 2:811-815.
61. Lanie AD, Jayaratne TE, Sheldon JP, et al.: Exploring the public understanding of basic genetic concepts. Journal of Genetic Counseling. 2004, 13:305-320.
62. Rose AL, Peters N, Shea JA, Armstrong K: Attitudes and misconceptions about predictive genetic testing for cancer risk. Community Genetics. 2005, 8:145-151.
63. Rose A, Peters N, Shea JA, Armstrong K: The association between knowledge and attitudes about genetic testing for cancer risk in the United States. Journal of Health Communication. 2005, 10:309-321.
64. Wideroff L, Vadaparampil ST, Breen N, Croyle RT, Freedman AN: Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genetics. 2003, 6:147-156.
65. Eisenbruch M, Yeo SS, Meiser B, et al.: Optimising clinical practice in cancer genetics with cultural competence: Lessons to be learned from ethnographic research with Chinese-Australians. Social Science & Medicine. 2004, 59:235-248.
66. Kenen R, Arden-Jones A, Eeles R: We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC). Psychooncology. 2004, 13:335-345.
67. Richards M: Annotation: Genetic research, family life, and clinical practice. Journal of Child Psychology and Psychiatry. 1998, 39:291-305.
68. Richards M, Ponder M: Lay understanding of genetics: a test of a hypothesis. Journal of Medical Genetics. 1996, 33:1032-1036.
69. Henderson BJ, Maguire BT. Three lay mental models of disease inheritance. Social Science & Medicine. 2000, 50:293-301.
70. Rogers EM: Diffusions of Innovations (4th Ed.). New York: The Free Press, 1995.
71. McCombs M: News influence on our pictures of the world. In Bryant J, Zillmann D (eds), Media Effects. Advances in Theory and Research. Hillsdale, NJ: Lawrence Erlbaum Associates, 1994, 1-17.
72. Gerbner G, Gross L, Morgan M, Signorielli N: Growing up with television: The cultivation perspective. In Bryant J, Zillmann D (eds), Media Effects. Advances in Theory and Research. Hillsdale, NJ: Lawrence Erlbaum Associates, 1994, 17-43.
73. Solomon DS: A social marketing perspective on communication campaigns. In Rice RE, Atkin CK (eds), Public Communication Campaigns (2nd Ed.). Newbury Park: Sage, 1989, 87-104.
74. Maibach EW, Rothschild ML, Novelli WD: Social marketing. In Glanz K, Rimer BK, Lewis FM (eds), Health Behavior and Health Education. Theory, Research and Practice (3rd Ed.). San Francisco: Jossey-Bass, 2002.
75. Petty RE, Cacioppo JT: Attitudes and Persuasion: Classic and Contemporary Approaches. Dubuque, IA: Brown, 1981.
76. Petty RE, Priester JR: Mass media attitude change: Implications of the elaboration likelihood model of persuasion. In Bryant J, Zillmann D (eds), Media Effects. Advances in Theory and Research. Hillsdale, NJ: Lawrence Erlbaum Associates, 1994, 91-122.
77. Ong LM, de Haes JC, Hoos AM, Lammes FB: Doctor-patient communication: A review of the literature. Social Science & Medicine. 1995, 40:903-918.
78. Dutta-Bergman MJ: The relation between health-orientation, provider-patient communication, and satisfaction: An individual-difference approach. Health Communication. 2005, 18:291-303.
79. Dutta-Bergman MJ: Developing a profile of consumer intention to seek out additional information beyond a doctor: The role of communicative and motivation variables. Health Communication. 2005, 17:1-16.
80. Dutta-Bergman MJ: The readership of health magazines: The role of health orientation. Health Marking Quarterly. 2004, 22:27-49.
81. Omenn GS: Genomics and public health: A vision for the future. In Hernanadez LM (ed), Implications of Genomics for Public Health: Workshop Summary. Washington DC: Institute of Medicine, The National Academies Press, 2005, 5.
82. Oldenburg B, Parcel GS: Diffusion of innovations. In Glanz K, Rimer BK, Lewis FM (eds), Health Behavior and Health Education: Theory, Research, and Practice (3rd Ed.). New York: Jossey-Bass, 2002, 312-334.
83. Burke W: Genetic testing in primary care. Annual Review of Genomics and Human Genetics. 2004, 5:1-14.
84. Burke W, Acheson L, Botkin J, et al.: Genetics in primary care: A USA faculty development initiative. Community Genetics. 2002, 5:138-146.
85. Burke W, Emery J: Genetics education for primary-care providers. Nature reviews. Genetics. 2002, 3:561-566.
86. Gramling R, Nash J, Siren K, Culpepper L: Predictive genetics in primary care: Expectations for the motivational impact of genetic testing affects the importance family physicians place on screening for familial cancer risk. Genetics in Medicine. 2003, 5:172-175.
87. Culler D, Grimes SJ, Acheson LS, Wiesner GL: Cancer genetics in primary care. Primary Care. 2004, 31: 649-683, xi.
88. Hesse BW, Nelson DE, Kreps GL, et al.: Trust and sources of health information: The impact of the Internet and its implications for health care providers: Findings from the first Health Information National Trends Survey. Archives of Internal Medicine. 2005, 165:2618-2624.
89. Bowen DJ, Burke W, Press NA, et al.: Recruiting families into prevention research: The suntalk study. Annals of Behavioral Medicine. 2005, 33:S018.
90. Karliner LS, Napoles-Springer A, Kerlikowske K, et al.: Missed opportunities: Family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women. Journal of General Internal Medicine. 2007, 22:308-314.
91. Ziogas A, Anton-Culver HL: Validation of family history data in cancer family registries. American Journal of Preventive Medicine. 2003, 24:190-198.
92. Shields AE, Blumenthal D, Weiss KB, et al.: Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. Journal of General Internal Medicine. 2005, 20:131-138.
93. Barrison AF, Smith C, Oviedo J, Heeren T, Schroy III PC: Colorectal cancer screening and familial risk: A survey of internal medicine residents' knowledge and practice patterns. The American Journal of Gastroenterology. 2003, 98:1410-1416.
94. Gramling R, Nash J, Siren K, Eaton C, Culpepper L: Family physician self-efficacy with screening for inherited cancer risk. Annals of Family Medicine. 2004, 2:130-132.
95. Wideroff L, Vadaparampil ST, Greene MH, et al.: Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. Journal of Medical Genetics. 2005, 42:749-755.
96. Schroy III PC, Barrison AF, Ling BS, Wilson S, Geller AC: Family history and colorectal cancer screening: A survey of physician knowledge and practice patterns. The American Journal of Gastroenterology. 2002, 97:1031-1036.
97. Kefford RF, Newton Bishop JA, Bergman W, Tucker MA: Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium. Journal of Clinical Oncology. 1999, 17:3245-3251.
98. Armstrong K, Weber B, Ubel PA, Guerra C, Schwartz JS: Interest in BRCA1/2 testing in a primary care population. Preventive Medicine. 2002, 34:590-595.
99. White DB, Jenkins J, Vonham V, Stevens N, McBride CM: Too many referrals for BRCA1 and BRCA2 genetic services by family physicians? Annals of Behavioral Medicine. 2007, 33:S093.
100. Gramling R, Anthony D, Lowery J, et al.: Association between screening family medical history in general medical care and lower burden of cancer worry among women with a close family history of breast cancer. Genetics in Medicine. 2005, 7:640-645.
101. Blazer KR, MacDonald DJ, Ricker C, et al.: Outcomes from intensive training in genetic cancer risk counseling for clinicians. Genetics in Medicine. 2005, 7:40-47.
102. Piniewski-Bond J, Celestino PB, Mahoney MC, et al: A cancer genetics education campaign: Delivering parallel messages to clinicians and the public. Journal of Cancer Education. 2003, 18:96-99.
103. Centers for Disease Control and Prevention, Office of Genomics and Disease Prevention: Genomics and Population Health, United States, 2003. Atlanta, GA: Centers for Disease Control and Prevention, Office of Genomics and Disease Prevention, 2004.
104. Marteau TM, Lerman C: Genetic risk and behavioural change. British Medical Journal. 2001, 322:1056-1059.
105. Frosch DL, Mello P, Lerman C: Behavioral consequences of testing for obesity risk. Cancer Epidemiology, Biomarkers & Prevention. 2005, 14:1485-1489.
106. Ryder K, Haubrich DJ, Calla D, et al.: Psychosocial impact of repeat HIV-negative testing: A follow-up study. AIDS and Behavior. 2005, 9:459-464.
107. Audrain-McGovern J, Hughes C, Patterson F: Effecting behavior change: Awareness of family history. American Journal of Preventive Medicine. 2003, 24:183-189.
108. Bowen DJ, Ludman E, Press N, Vu T, Burke W: Achieving utility with family history: Colorectal cancer risk. American Journal of Preventive Medicine. 2003, 24: 177-182.
109. Burke W: Taking family history seriously. Annals of Internal Medicine. 2005, 143:388-389.
110. Guttmacher AE, Collins FS, Carmona RH: The family history - More important than ever. New England Journal of Medicine. 2004, 351:2333-2336.
111. Yoon PW, Scheuner MT, Peterson-Oehlke KL, et al.: Can family history be used as a tool for public health and preventive medicine? Genetics in Medicine. 2002, 4: 304-310.
112. Lipkus IM, McBride CM, Pollak KI, Lyna P, Bepler G: Interpretation of genetic risk feedback among African American smokers with low socioeconomic status. Health Psychology. 2004, 23:178-188.
113. McBride CM, Bepler G, Lipkus IM, et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology, Biomarkers & Prevention. 2002, 11:521-528.
114. McBride CM, Lipkus IM, Jolly D, Lyna P: Interest in testing for genetic susceptibility to lung cancer among Black college students "at risk" of becoming cigarette smokers. Cancer Epidemiology, Biomarkers & Prevention. 2005, 14:2978-2981.
115. McBride CM, Pollak KI, Bepler G, et al: Reasons for quitting smoking among low-income African American smokers. Health Psychology. 2001, 20:334-340.
116. McBride CM, Halabi S, Bepler G, et al.: Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit. Journal of Health Communication. 2000, 5:229-241.
117. Ostroff JS, Hay JL, Primavera LH, et al.: Motivating smoking cessation among dental patients: Smokers' interest in biomarker testing for susceptibility to tobacco-related cancers. Nicotine & Tobacco Research. 1999, 1: 347-355.
118. Lerman C, Gold K, Audrain J, et al.: Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: Effects on smoking-related cognitions, emotions, and behavior change. Health Psychology. 1997, 16:87-99.
119. McClure JB. Are biomarkers a useful aid in smoking cessation? A review and analysis of the literature. Behavioral Medicine. 2001, 27:37-47.
120. Merikangas KR, Risch N: Genomic priorities and public health. Science. 2003, 302:599-601.
121. Carlsten C, Burke W: Potential for genetics to promote public health: Genetics research on smoking suggests caution about expectations. Journal of the American Medical Association. 2006, 296:2480-2482.
122. Shostak S: Locating gene-environment interaction: At the intersections of genetics and public health. Social Science & Medicine. 2003, 56:2327-2342.
123. Sallis JF, Owen N: Ecological models of health behavior. In Glanz K, Rimer BK, Lewis FM (eds), Health Behavior and Health Education: Theory, Research, and Practice (3rd Ed.). New York: Jossey-Bass, 2002, 462-484.
124. Bowen DJ, Beresford SAA, Diergaarde B: Social and psychological aspects of ecogenetics. In Costa LG, Eaton DL (eds), Gene-Environment Interactions: Fundamentals of Ecogenetics. New York: Wiley-Liss, 2006, 397-409.
125. Stokols D: Translating social ecological theory into guidelines for community health promotion. American Journal of Health Promotion. 1996, 10:282-298.
126. Wang C, Bowen DJ, Kardia SL: Research and practice opportunities at the intersection of health education, health behavior, and genomics. Health Education & Behavior. 2005, 32:686-701.
127. Novilla ML, Barnes MD, De La Cruz NG, Williams PN, Rogers J: Public health perspectives on the family: An ecological approach to promoting health in the family and community. Family Community Health. 2006, 29: 28-12.
128. Buller DB, Buller MK, Kane I: Web-based strategies to disseminate a sun safety curriculum to public elementary schools and state-licensed child-care facilities. Health Psychology. 2005, 24:470-476.
129. Glanz K, Steffen A, Elliott T, O'Riordan D: Diffusion of an effective skin cancer prevention program: Design, theoretical foundations, and first-year implementation. Health Psychology. 2005, 24:477-487.
130. Lewis E, Mayer JA, Slymen D, et al.: Disseminating a sun safety program to zoological parks: The effects of tailoring. Health Psychology. 2005, 24:456-462.
131. Kardia S: Bridging genomics and population health. In Hernandez LM (ed), Implications of Genomics for Public Health: Workshop Summary. Washington, DC: Institute of Medicine, The National Academies Press, 2005, 10.
132. Garraway LA, Widlund HR, Rubin MA, et al.: Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005, 436:117-122.
133. Curtin JA, Fridlyand J, Kageshita T, et al.: Distinct sets of genetic alterations in melanoma. New England Journal of Medicine. 2005, 353:2135-2147.
134. Landi MT, Bauer J, Pfeiffer RM, et al.: MC1R germline variants confer risk for BRAF-mutant melanoma. Science. 2006, 313:521-522.